Somatuline Autogel 60 mg / 90 mg / 120 mg Solution for injection
PDF Leaflet Revision Date: 16 January 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of acromegaly and neuroendocrine tumors.
Dosage (summary)
Starting dose 90 mg every 28 days; adjust based on response.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Ciclosporin
- Insulin and antidiabetic agents
- Bradycardia-inducing medications
Contraindications
- Hypersensitivity to lanreotide
- Untreated biliary lithiasis
- Pregnancy and lactation
Common side effects
- Diarrhoea
- Abdominal pain
- Cholelithiasis
- Injection site reactions
Counselling Points
- Monitor for gastrointestinal side effects
- Report any signs of gallbladder issues
- Adjust antidiabetic medications as needed
Serious warnings
- Risk of gallbladder complications
- Monitor blood glucose levels
- Potential for bradycardia
Important Disclaimer
The Somatuline Autogel 60 mg / 90 mg / 120 mg Solution for injection professional information leaflet below is the property of Acino Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
